Research ExplorerPublicationsUse of extracorporeal circulation (ECLS/ECMO) for cardiac an...

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3

Standard

Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3. / Assmann, Alexander; Beckmann, Andreas; Schmid, Christof; Werdan, Karl; Michels, Guido; Miera, Oliver; Schmidt, Florian; Klotz, Stefan; Starck, Christoph; Pilarczyk, Kevin; Rastan, Ardawan; Burckhardt, Marion; Nothacker, Monika; Müllenbach, Ralf; Zausig, York; Haake, Nils; Groesdonk, Heinrich; Ferrari, Markus; Buerke, Michael; Hennersdorf, Marcus; Rosenberg, Mark; Schaible, Thomas; Köditz, Harald; Kluge, Stefan; Janssens, Uwe; Lubnow, Matthias; Flemmer, Andreas; Herber-Jonat, Susanne; Wessel, Lucas; Buchwald, Dirk; Maier, Sven; Krüger, Lars; Fründ, Andreas; Jaksties, Rolf; Fischer, Stefan; Wiebe, Karsten; Hartog, Christiane S; Dzemali, Omer; Zimpfer, Daniel; Ruttmann-Ulmer, Elfriede; Schlensak, Christian; Kelm, Malte; Ensminger, Stephan; Boeken, Udo.

In: ESC HEART FAIL, Vol. 9, No. 1, 02.2022, p. 506-518.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Assmann, A, Beckmann, A, Schmid, C, Werdan, K, Michels, G, Miera, O, Schmidt, F, Klotz, S, Starck, C, Pilarczyk, K, Rastan, A, Burckhardt, M, Nothacker, M, Müllenbach, R, Zausig, Y, Haake, N, Groesdonk, H, Ferrari, M, Buerke, M, Hennersdorf, M, Rosenberg, M, Schaible, T, Köditz, H, Kluge, S, Janssens, U, Lubnow, M, Flemmer, A, Herber-Jonat, S, Wessel, L, Buchwald, D, Maier, S, Krüger, L, Fründ, A, Jaksties, R, Fischer, S, Wiebe, K, Hartog, CS, Dzemali, O, Zimpfer, D, Ruttmann-Ulmer, E, Schlensak, C, Kelm, M, Ensminger, S & Boeken, U 2022, 'Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3', ESC HEART FAIL, vol. 9, no. 1, pp. 506-518. https://doi.org/10.1002/ehf2.13718

APA

Assmann, A., Beckmann, A., Schmid, C., Werdan, K., Michels, G., Miera, O., Schmidt, F., Klotz, S., Starck, C., Pilarczyk, K., Rastan, A., Burckhardt, M., Nothacker, M., Müllenbach, R., Zausig, Y., Haake, N., Groesdonk, H., Ferrari, M., Buerke, M., ... Boeken, U. (2022). Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3. ESC HEART FAIL, 9(1), 506-518. https://doi.org/10.1002/ehf2.13718

Vancouver

Assmann A, Beckmann A, Schmid C, Werdan K, Michels G, Miera O et al. Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3. ESC HEART FAIL. 2022 Feb;9(1):506-518. https://doi.org/10.1002/ehf2.13718

Bibtex

@article{818873fddaa04a7ebacefcc641f4aedc,
title = "Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3",
abstract = "Aims Worldwide applications of extracorporeal circulation for mechanical support in cardiac and circulatory failure, which are referred to as extracorporeal life support (ECLS) or veno-arterial extracorporeal membrane oxygenation (va-ECMO), have dramatically increased over the past decade. In spite of the expanding use and the immense medical as well as socio-economic impact of this therapeutic approach, there has been a lack of interdisciplinary recommendations considering the best available evidence for ECLS treatment. Methods and Results In a multiprofessional, interdisciplinary scientific effort of all scientific societies involved in the treatment of patients with acute cardiac and circulatory failure, the first evidence- and expert consensus-based guideline (level S3) on ECLS/ECMO therapy was developed in a structured approach under regulations of the AWMF (Association of the Scientific Medical Societies in Germany) and under use of GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. This article presents all recommendations created by the expert panel, addressing a multitude of aspects for ECLS initiation, continuation, weaning and aftercare as well as structural and personnel requirements. Conclusions This first evidence- and expert consensus-based guideline (level S3) on ECLS/ECMO therapy should be used to apply the best available care nationwide. Beyond clinical practice advice, remaining important research aspects for future scientific efforts are formulated.",
author = "Alexander Assmann and Andreas Beckmann and Christof Schmid and Karl Werdan and Guido Michels and Oliver Miera and Florian Schmidt and Stefan Klotz and Christoph Starck and Kevin Pilarczyk and Ardawan Rastan and Marion Burckhardt and Monika Nothacker and Ralf M{\"u}llenbach and York Zausig and Nils Haake and Heinrich Groesdonk and Markus Ferrari and Michael Buerke and Marcus Hennersdorf and Mark Rosenberg and Thomas Schaible and Harald K{\"o}ditz and Stefan Kluge and Uwe Janssens and Matthias Lubnow and Andreas Flemmer and Susanne Herber-Jonat and Lucas Wessel and Dirk Buchwald and Sven Maier and Lars Kr{\"u}ger and Andreas Fr{\"u}nd and Rolf Jaksties and Stefan Fischer and Karsten Wiebe and Hartog, {Christiane S} and Omer Dzemali and Daniel Zimpfer and Elfriede Ruttmann-Ulmer and Christian Schlensak and Malte Kelm and Stephan Ensminger and Udo Boeken",
year = "2022",
month = feb,
doi = "10.1002/ehf2.13718",
language = "English",
volume = "9",
pages = "506--518",
journal = "ESC HEART FAIL",
issn = "2055-5822",
publisher = "The Heart Failure Association of the European Society of Cardiology",
number = "1",

}

RIS

TY - JOUR

T1 - Use of extracorporeal circulation (ECLS/ECMO) for cardiac and circulatory failure -A clinical practice Guideline Level 3

AU - Assmann, Alexander

AU - Beckmann, Andreas

AU - Schmid, Christof

AU - Werdan, Karl

AU - Michels, Guido

AU - Miera, Oliver

AU - Schmidt, Florian

AU - Klotz, Stefan

AU - Starck, Christoph

AU - Pilarczyk, Kevin

AU - Rastan, Ardawan

AU - Burckhardt, Marion

AU - Nothacker, Monika

AU - Müllenbach, Ralf

AU - Zausig, York

AU - Haake, Nils

AU - Groesdonk, Heinrich

AU - Ferrari, Markus

AU - Buerke, Michael

AU - Hennersdorf, Marcus

AU - Rosenberg, Mark

AU - Schaible, Thomas

AU - Köditz, Harald

AU - Kluge, Stefan

AU - Janssens, Uwe

AU - Lubnow, Matthias

AU - Flemmer, Andreas

AU - Herber-Jonat, Susanne

AU - Wessel, Lucas

AU - Buchwald, Dirk

AU - Maier, Sven

AU - Krüger, Lars

AU - Fründ, Andreas

AU - Jaksties, Rolf

AU - Fischer, Stefan

AU - Wiebe, Karsten

AU - Hartog, Christiane S

AU - Dzemali, Omer

AU - Zimpfer, Daniel

AU - Ruttmann-Ulmer, Elfriede

AU - Schlensak, Christian

AU - Kelm, Malte

AU - Ensminger, Stephan

AU - Boeken, Udo

PY - 2022/2

Y1 - 2022/2

N2 - Aims Worldwide applications of extracorporeal circulation for mechanical support in cardiac and circulatory failure, which are referred to as extracorporeal life support (ECLS) or veno-arterial extracorporeal membrane oxygenation (va-ECMO), have dramatically increased over the past decade. In spite of the expanding use and the immense medical as well as socio-economic impact of this therapeutic approach, there has been a lack of interdisciplinary recommendations considering the best available evidence for ECLS treatment. Methods and Results In a multiprofessional, interdisciplinary scientific effort of all scientific societies involved in the treatment of patients with acute cardiac and circulatory failure, the first evidence- and expert consensus-based guideline (level S3) on ECLS/ECMO therapy was developed in a structured approach under regulations of the AWMF (Association of the Scientific Medical Societies in Germany) and under use of GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. This article presents all recommendations created by the expert panel, addressing a multitude of aspects for ECLS initiation, continuation, weaning and aftercare as well as structural and personnel requirements. Conclusions This first evidence- and expert consensus-based guideline (level S3) on ECLS/ECMO therapy should be used to apply the best available care nationwide. Beyond clinical practice advice, remaining important research aspects for future scientific efforts are formulated.

AB - Aims Worldwide applications of extracorporeal circulation for mechanical support in cardiac and circulatory failure, which are referred to as extracorporeal life support (ECLS) or veno-arterial extracorporeal membrane oxygenation (va-ECMO), have dramatically increased over the past decade. In spite of the expanding use and the immense medical as well as socio-economic impact of this therapeutic approach, there has been a lack of interdisciplinary recommendations considering the best available evidence for ECLS treatment. Methods and Results In a multiprofessional, interdisciplinary scientific effort of all scientific societies involved in the treatment of patients with acute cardiac and circulatory failure, the first evidence- and expert consensus-based guideline (level S3) on ECLS/ECMO therapy was developed in a structured approach under regulations of the AWMF (Association of the Scientific Medical Societies in Germany) and under use of GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. This article presents all recommendations created by the expert panel, addressing a multitude of aspects for ECLS initiation, continuation, weaning and aftercare as well as structural and personnel requirements. Conclusions This first evidence- and expert consensus-based guideline (level S3) on ECLS/ECMO therapy should be used to apply the best available care nationwide. Beyond clinical practice advice, remaining important research aspects for future scientific efforts are formulated.

U2 - 10.1002/ehf2.13718

DO - 10.1002/ehf2.13718

M3 - SCORING: Journal article

C2 - 34811959

VL - 9

SP - 506

EP - 518

JO - ESC HEART FAIL

JF - ESC HEART FAIL

SN - 2055-5822

IS - 1

ER -